Wed, Sep 17, 2014, 6:33 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

PDL BioPharma, Inc. Message Board

innsbrooklad 421 posts  |  Last Activity: 4 hours ago Member since: Nov 11, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Any dilution this year?

    by llyynn08 5 hours ago
    innsbrooklad innsbrooklad 4 hours ago Flag

    Upon approval I think they will raise capital or may have a deal cooking for a collaboration. I reiterate my
    strong feeling that the science we practice is going to grow exponentially. There are a lot of nerves in the body
    and we are only focusing on one. They have the 13 centers which will be up and running and hopefully their
    woeful outside IR/PR firm can do something other that take up space.

  • Reply to

    Strong

    by lagafroig 8 hours ago
    innsbrooklad innsbrooklad 4 hours ago Flag

    Hate is a relative term. I hate asparagus too. Bob is over his head and has told me and others and in conference calls that
    he was going to do several deals this year. When he does I will pay attention.

    Street sniffing news? Olfactory prowess has a tendency to
    embarrass Wall Street.

  • Reply to

    Strong

    by lagafroig 8 hours ago
    innsbrooklad innsbrooklad 5 hours ago Flag

    I am a Mulroy hater so I will add to my position after they announce something. I do
    not know why it is up here as they have no NDA filed and still a lot of promises.
    I think they could also be getting ready for a financing. Also Friday is expiration and there are 5700 7 1/2 calls so the options guys may try to close the stock there.
    I am really trying to ignore MACK until I see something real. They have 6 months of cash and that is not comfortable.

    Sentiment: Hold

  • Reply to

    Strong

    by lagafroig 8 hours ago
    innsbrooklad innsbrooklad 6 hours ago Flag

    Do you sit on a prayer rug all day????

    Sentiment: Hold

  • innsbrooklad innsbrooklad 6 hours ago Flag

    Manufacture is easy. They have thought of that already and can probably scale up with the present device pretty quick. It is the research and the miniaturization that will focus their efforts if they get the capital. And the sales end? They are not going there. They will license the device. They have bigger fish to fry in the science and hopefully they have the sense to go in that direction.

  • Reply to

    Level II

    by jeffjustin306 7 hours ago
    innsbrooklad innsbrooklad 6 hours ago Flag

    When you have bashers and short sellers on a stock at this price they sell it to each other if they can't get a pair of weak hands to sell. You could also coax an institution into selling with the thought
    of buying it back cheaper. But we are at what I can going out of business levels and why anyone would short a short down here when we are in front of the FDA boggles my mind. On approval we will get a boost then they will try to knock it down but by then idiots like SA and Cramer will start talking.
    You saw what happened in OREX. They took us and ARNA and VVUS down. It is the old adage,
    " When they raid the cat house they take the piano player too."

    I just ignore the day to day baloney. I have read and reread the documents and the results and the comments and am very confident we will get approval with a minimum warning label. With a lot of the trial done at Mayo and the subsequent results I find the odds of a negative FDA decision quite small.
    If they actually did 200,000 bariatric surgeries last year I still stand by my estimate that we will do
    50,000 in the first 18 months. I use $5,000 as the initial device cost. Do the math.

    The big picture is still my fundamentally the science and the patent estate. Selling to a device company would, in my estimation be an error. You see Glaxo putting $50 Million in the electroceutical
    business. The gave Dr. Tracey a few million. If we get approval, I would urge the company to seek out Tracey and buy his company.

    Sentiment: Strong Buy

  • Reply to

    desperation ..........

    by eqtyinvstr 8 hours ago
    innsbrooklad innsbrooklad 8 hours ago Flag

    You can see the volume totally dried up. There are 7.6 million shares short. Between institutions and management they own 60% of the float and we own the rest.

    Sentiment: Strong Buy

  • innsbrooklad innsbrooklad 19 hours ago Flag

    Good points. But you guys are missing the big picture. VBLOC is the tip of the ice berg. They already have the next generation and they have plans for new devices in new indications. If you think this is a one trick pony you are quite mistaken. They will be doing wireless within six months. Like Dr. Tracey did with
    rheumatoid arthritis, we will attack nodes to a lot of indications and use the wireless signal. This will be
    useful in many neuropathies, and possibly issues like sciatica. This is a whole new scientific episode and
    if you bought this stock for a quick trip you will be disappointed. The will get FDA approval for VBLOC, sell the
    international rights as they are already approved and will start clinical trials with new partners who will upfront
    big money.

    WE ARE A DEVICE COMPANY NOT A PILL COMPANY THAT DOES GOOD SCIENCE.

    Sentiment: Strong Buy

  • Reply to

    Remember ETRM Director Paid $1.70 In June

    by dctrig Sep 16, 2014 4:49 PM
    innsbrooklad innsbrooklad Sep 16, 2014 5:39 PM Flag

    Without HFT and corporate buybacks you could close the NYSE. Look at the volume in the last year.
    Down 30%? Get rid of ETFs and you do not need the markets.

  • innsbrooklad innsbrooklad Sep 16, 2014 3:40 PM Flag

    What does not add up is we are not paying high enough bribes.

  • Reply to

    The Street comes out with rating .....

    by eqtyinvstr Sep 16, 2014 1:26 PM
    innsbrooklad innsbrooklad Sep 16, 2014 3:38 PM Flag

    Insiders options are also a lot higher than today's price.

  • Reply to

    Premarket

    by storm3113 Sep 16, 2014 7:33 AM
    innsbrooklad innsbrooklad Sep 16, 2014 7:47 AM Flag

    Stock has not traded. Ever think it could be JP Morgan jacking the stock for a deal?

  • Reply to

    recalibrated PPS post approval

    by tiktokstock Sep 16, 2014 1:15 AM
    innsbrooklad innsbrooklad Sep 16, 2014 7:44 AM Flag

    After approval who cares what the price does? You can't compare us to OREX or any of the other pill companies because they can't sell their products. If they get approved they sell the international rights as they already have approval for the device in Europe and Australia. Asian approval will be easy for the licensee. They start selling the product here and introduce the smaller model or a wireless model. They have the cash to start the process.
    Management owns a lot of stock via options at a much higher price. You will not get a $5.00 buyout. Folly!

  • Reply to

    ETRM CEO sleeping ????

    by pooja_anglelove_82 Sep 15, 2014 8:43 PM
    innsbrooklad innsbrooklad Sep 16, 2014 7:34 AM Flag

    When you are in front of the FDA with your first product you tend to be very introspective. The FDA follows everything the company does and says, even I imagine this message board. While it seems strange you will get all your answers before year end. The ADCOM was dysfunctional because the FDA set up a
    dysfunctional trial. OREX blew up as did ARNA and VVUS. Some of those fellows were here dissing the stock and now they were in the foxhole when the grenade went off. The price of this stock is a cheap option on a great technology. You know your downside. Why did you buy this stock in the first place?

    Sentiment: Strong Buy

  • Reply to

    ETRM CEO sleeping ????

    by pooja_anglelove_82 Sep 15, 2014 8:43 PM
    innsbrooklad innsbrooklad Sep 16, 2014 7:27 AM Flag

    Let me explain something to you as you most likely have done no due diligence. They have one product currently but they have a huge patent estate in a new science. Read the May 23 New York Times Magazine article called " Hacking the Human Body." You will get an education. Comments like yours show just how much you don't know. College freshman?

  • Reply to

    NDA has been filed

    by uvainvestor82 Sep 15, 2014 7:59 PM
    innsbrooklad innsbrooklad Sep 15, 2014 10:34 PM Flag

    Tell me the date and the time stamp on the form from the FDA.

  • Reply to

    Hovering at my cost basis

    by kelvin_archer Sep 15, 2014 2:46 PM
    innsbrooklad innsbrooklad Sep 15, 2014 5:53 PM Flag

    If you have to worry about your cost basis you may have to buy a case of Maalox. I was long
    AMGN at $1.87 way back when and it was cut in half..I still own my original position.
    Do not worry about your cost. Worry about your grasp on the English language and your ability to read a 10K.

    You own the company cheap...Take a vacation.

    Sentiment: Strong Buy

  • Reply to

    Hovering at my cost basis

    by kelvin_archer Sep 15, 2014 2:46 PM
    innsbrooklad innsbrooklad Sep 15, 2014 5:11 PM Flag

    Educate me...Why do you care about your cost basis??? Make your cost basis lower..sell some December calls.

  • Reply to

    After Hours

    by uvainvestor82 Sep 15, 2014 4:15 PM
    innsbrooklad innsbrooklad Sep 15, 2014 5:10 PM Flag

    Does it bother you that they had the 398 data in June, it is an orphan drug, and they have
    not yet filed an NDA?

    FYI..For every buyer..there was a seller. Good luck to you..

    Sentiment: Hold

  • Reply to

    Could

    by lagafroig Sep 15, 2014 9:38 AM
    innsbrooklad innsbrooklad Sep 15, 2014 2:49 PM Flag

    Look at it this way. We have a market cap of $750MM currently, Why would any pharma company give us a load of cash. Hell, they could buy 15% quietly here and bid for the rest. He can't make a deal that will prevent a financing and if he finances before a deal he is going to get sued as is the board. Being on the record is dangerous.

    MACK's pipeline??? Sanofi gave 121 back. And where is the NDA for MM 398? It was an orphan drug as I remember. That should have been done
    two months ago.

    I may buy some out of the money puts as insurance...Bob M. falls again we will be selling stock at $4.00.

    Sentiment: Hold

PDLI
8.48-1.17(-12.12%)Sep 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.